Retrogenix Limited

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Retrogenix is a fast-growing biotechnology company specialising in identifying protein interactions in human cells. The technology is widely used by major global pharmaceutical companies to advance drug discovery and assist with safety assessment; predominantly in biologics research.

Retrogenix's human cell microarray platform uncovers the primary receptors and potential off-target activities for a variety of ligands, including antibodies, proteins, small molecules, viruses and cell therapies such as CAR T. Thousands of plasma membrane and secreted proteins are overexpressed in human cells allowing physiologically relevant interactions to be identified with very high sensitivity and specificity. Retrogenix has won two Queen’s Awards for Enterprise – the UK’s most prestigious business accolade. The first award recognised the company's innovative work and the second award was for international trade.

Retrogenix is headquartered near Manchester, UK, and has a US office in Cambridge, MA
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
United Kingdom
Year Founded:
2008
Main Therapeutic Focus:
Lead Product in Development:
Cell Microarray Technology
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
North American Business Development Manager
Retrogenix Limited